Followers | 247 |
Posts | 49952 |
Boards Moderated | 51 |
Alias Born | 08/29/2007 |
Sunday, January 21, 2024 6:23:59 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ELTX News
- Elicio Therapeutics to Present New Preliminary Data from the Ongoing AMPLIFY-7P Phase 1/2 Study of ELI-002 7P in Patients with mKRAS-driven Solid Tumors at the 2024 ASCO Annual Meeting • GlobeNewswire Inc. • 04/25/2024 12:30:00 PM
- Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting • GlobeNewswire Inc. • 04/05/2024 08:30:00 PM
- Elicio Therapeutics Reports 2023 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 03/29/2024 12:30:00 PM
- Elicio Therapeutics Announces $6.0 Million Private Placement Financing • GlobeNewswire Inc. • 03/18/2024 12:00:00 PM
- Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/05/2024 01:30:00 PM
- Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating TCR-T Cell Therapy in Combination with Lymph Node-Targeted Amphiphile-Immunotherapy Enhanced Anti-Tumor Function and Eradicated Solid Tumors • GlobeNewswire Inc. • 01/25/2024 02:00:00 PM
- Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium • GlobeNewswire Inc. • 01/17/2024 01:30:00 PM
- Elicio Therapeutics to Present at the B. Riley Securities 4th Annual Oncology Conference • GlobeNewswire Inc. • 01/16/2024 01:30:00 PM
- Elicio Therapeutics Announces First Patient Dosed in Randomized Phase 2 Pancreatic Cancer Study • GlobeNewswire Inc. • 01/11/2024 01:30:00 PM
- Nature Medicine Publishes Updated Preliminary Phase 1 Data From Elicio Therapeutic’s AMPLIFY-201 Phase 1 Solid Tumor Study of ELI-002 • GlobeNewswire Inc. • 01/09/2024 11:00:00 AM
- Elicio Therapeutics Announces $7.0 Million Private Placement Financing • GlobeNewswire Inc. • 12/22/2023 02:00:32 PM
- Elicio Therapeutics to Present at the H.C. Wainwright 4th Annual Precision Oncology Virtual Conference • GlobeNewswire Inc. • 12/04/2023 01:00:00 PM
- Elicio Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 11/09/2023 09:30:00 PM
- Elicio Therapeutics Presents Updated Preliminary Immunogenicity Data from the Ongoing Phase 1 Study of ELI-002 and New Preclinical Data on ELI-007 and ELI-008 at the Society for Immunotherapy of Cancer (SITC 2023) Annual Meeting • GlobeNewswire Inc. • 11/03/2023 08:30:00 PM
- Elicio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer’s (SITC 2023) Annual Meeting • GlobeNewswire Inc. • 10/11/2023 12:00:00 PM
- Elicio Therapeutics Presents Updated Preliminary Data Including Promising Relapse-Free Survival Data from the Phase 1 Study of ELI-002 at AACR Special Conference: Pancreatic Cancer • GlobeNewswire Inc. • 09/27/2023 09:30:00 PM
- Elicio Therapeutics Receives $2.6 Million Grant from the Gastro-Intestinal (GI) Research Foundation to Fund Research for Two Therapeutic Cancer Vaccines • GlobeNewswire Inc. • 09/07/2023 12:00:00 PM
- Elicio Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/06/2023 12:00:00 PM
- Elicio Therapeutics to Present Phase 1 Data on Cancer Vaccine Candidate, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancers at the AACR Special Conference on Pancreatic Cancer • GlobeNewswire Inc. • 09/05/2023 12:00:00 PM
- Elicio Therapeutics Announces Appointment of Megan Filoon as General Counsel and Dr. Thian Kheoh as Senior Vice President of Biometrics • GlobeNewswire Inc. • 08/28/2023 12:00:00 PM
- Elicio Therapeutics Reports Inducement Grants • GlobeNewswire Inc. • 08/22/2023 08:30:00 PM
- Elicio Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Updates • GlobeNewswire Inc. • 08/11/2023 12:30:54 PM
- Elicio Therapeutics Announces Publication of Preclinical Data Demonstrating AMP-CpG Adjuvant Can Induce Potent and Durable Immune Response in Epstein-Barr Virus (EBV) Infectious Disease Model • GlobeNewswire Inc. • 08/09/2023 12:00:00 PM
- Elicio Therapeutics Completes Reverse Merger and Provides a Corporate Update • GlobeNewswire Inc. • 06/06/2023 12:00:00 PM
- Elicio Therapeutics Announces Positive Interim Data from the Phase 1 Study of an Investigational Therapeutic Cancer Immunotherapy, ELI-002, in Patients with High Relapse Risk Pancreatic and Colorectal Cancer at the ASCO Annual Meeting • GlobeNewswire Inc. • 06/03/2023 01:00:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM